Actively Recruiting

Phase 2
Age: 19Years - 79Years
All Genders
Healthy Volunteers
NCT03984461

The Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis

Led by Dr. Grant M. Pagdin · Updated on 2024-11-15

240

Participants Needed

1

Research Sites

378 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

To demonstrate the efficacy of the combined use of platelet-rich plasma (PRP) with lipoaspirate and/or bone marrow aspirate in osteoarthritis of major joints, and to compare the outcomes achieved using three combinations: PRP plus lipoaspirate, PRP plus bone marrow aspirate, and PRP plus both lipoaspirate and bone marrow aspirate.

CONDITIONS

Official Title

The Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis

Who Can Participate

Age: 19Years - 79Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Capable of providing written informed consent and willing and able to follow the study requirements
  • Male or female aged 19 years or older at consent
  • Osteoarthritis in a major joint confirmed by imaging (x-ray or MRI) within the last year
  • Kellgren & Lawrence Grades 1 to 3 osteoarthritis
Not Eligible

You will not qualify if you...

  • Body mass index (BMI) greater than 35
  • Arthroscopic surgery to the treatment joint within the past 12 months
  • Cortisone or hyaluronic acid injection in the treatment joint within 3 months prior to stem cell injection
  • Unable to hold antiplatelet therapy as directed before the procedure
  • Kellgren & Lawrence Grade 4 osteoarthritis
  • Platelet count less than 100 x 10^9
  • Hemoglobin less than 100 g/L
  • Active infection with fever or elevated white blood cell count
  • Active cancer diagnosis
  • Autoimmune disorders such as rheumatoid arthritis or lupus
  • Pregnant women (due to potential fetal harm from x-rays); women who become pregnant during the study will stop treatment and imaging but may continue symptom follow-up
  • Allergies to lidocaine, heparin, or epinephrine

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Pagdin Health

Kelowna, British Columbia, Canada, V1Y 6T8

Actively Recruiting

Loading map...

Research Team

G

Grant Pagdin, MD

CONTACT

M

Michelle Murtha, MScN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here